InsiderTrades

Form 4 for STOK Stoke Therapeutics, Inc.

Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001415889-24-009999 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-03 2024-04-01 STOK Ticho Barry Chief MEDICAL Off M - OptEx $0.6 +442 11.9K +4% +$265.20
D 2024-04-03 2024-04-01 STOK Ticho Barry Chief MEDICAL Off S - Sale+OE $13.23 -9,426 2,485 -79% -$124.7K
D 2024-04-03 2024-04-01 STOK Ticho Barry Chief MEDICAL Off M - OptEx $0.00 -442 80.0K -0.5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-01 M A 442 $0.6 11,911 D — —
2 Common Common Stock 2024-04-01 S D 9,426 $13.23 2,485 D — — (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $13.55 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2024-04-01 M D 442 $0.00 80,000 D $0.6 · — to 2028-04-02 442 Common Stock (F3) This fully-vested option vested as to 1/4th of the total award on October 2, 2018, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.